CanSino Biologics Inc. (OTCMKTS:CASBF) Short Interest Down 46.0% in December

CanSino Biologics Inc. (OTCMKTS:CASBF) was the target of a significant decrease in short interest in the month of December. As of December 31st, there was short interest totalling 10,800 shares, a decrease of 46.0% from the December 15th total of 20,000 shares. Based on an average daily volume of 400 shares, the short-interest ratio is currently 27.0 days.

CanSino Biologics Stock Performance

OTCMKTS CASBF traded down C$0.25 on Tuesday, reaching C$3.30. The company had a trading volume of 1,020 shares, compared to its average volume of 1,255. CanSino Biologics has a fifty-two week low of C$1.86 and a fifty-two week high of C$4.35. The business has a 50 day moving average of C$3.92 and a two-hundred day moving average of C$3.10.

CanSino Biologics Company Profile

CanSino Biologics Inc develops, manufactures, and commercializes vaccines in the People's Republic of China. The company develops Convidecia and the Ad5-nCoV for Inhalation vaccines to recombinant novel coronavirus disease; Ad5-EBOV, an Ebola virus vaccine; and MCV2 and MCV4 vaccines for the prevention of N.